Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

By: via Benzinga
Actavis plc (NYSE: ACT) is bidding against Sanofi SA (NYSE: SNY) in an effort to acquire a Belgium-based over-the-counter drug maker, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.